Akot has already made an impact, playing a key role in guiding SRM University to a runners-up finish at the Khelo India University Games (KIUG) Rajasthan 2025.

Mumbai University (MU) has announced the timetable for its upcoming summer exams, offering students exam dates, seat numbers, ...

Mumbai University (MU) has announced the summer exam schedule for BCom, BSc, and BA students, including seat numbers and exam ...

Jaipur: When South Sudan’s Akot Becky Paul Macuei applied for a sports scholarship quota to study B.Sc. Biotechnology in ...

Mumbai University has unveiled summer exam dates for 1.2 lakh students, commencing April 1 for commerce and April 8 for arts ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

Reader, beware: You’re entering haunted grounds. Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're embracing the spooky spirit of ...

Ipsen is acquiring next-gen immuno-oncology biotech ImCheck Therapeutics for its investigational cancer combination therapy in a deal worth up to 1 billion euros (about $1.16 billion). The French ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...

Biotech company Genmab announced Sept. 29 it entered into an agreement to acquire all shares of Merus. The all-cash transaction is worth approximately $8 billion. Genmab is an international ...

Twelve thousand international workers uphold Massachusetts’s booming technology and biotech industries — including more than 1,000 workers in Cambridge. But new fees on H-1B visas could soon cripple ...